FLT3 mutations are associated with other molecular lesions in AML
- 4 September 2003
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 28 (1) , 19-23
- https://doi.org/10.1016/s0145-2126(03)00125-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cellsLeukemia, 2003
- Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocolLeukemia, 2002
- The roles of FLT3 in hematopoiesis and leukemiaBlood, 2002
- Core-binding factors in haematopoiesis and leukaemiaNature Reviews Cancer, 2002
- Role of FLT3 in leukemiaCurrent Opinion in Hematology, 2002
- Tyrosine kinase oncogenes in normal hematopoiesis and hematological diseaseOncogene, 2002
- Oncogenic tyrosine kinases and the dna-damage responseNature Reviews Cancer, 2002
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesBlood, 2001
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999